CANF - Can-Fite BioPharma Ltd.

QQQ $ 449.23 $ 13.30 (3.06 %)

DIA $ 395.05 $ 6.75 (1.74 %)

SPY $ 531.28 $ 11.99 (2.31 %)

TLT $ 96.15 $ 0.00 (0 %)

GLD $ 224.00 $ 3.46 (1.57 %)

Previous Close

$ 2.7

Open

Bid

$ 2.61 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.81 - $ 4.69

Volume

91,862

Average Volume

Market Cap

3.67B

Beta (5Y Monthly)

$ 0.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

EF Hutton Initiates Coverage On Can Fite B...
07/17/2024 12:28:21

EF Hutton analyst Jason Kolbert initiates coverage on Can Fite Biofarma (AMEX:CANF) with a Buy rating and announces Price Ta...

Can-Fite Submits Application To FDA For Or...
07/11/2024 11:04:30

Can-Fite plans to start shortly a Phase IIa clinical study that will be a multicenter open-label trial in patients with advance...

Can-Fite Biopharma Announced That A Patien...
07/01/2024 11:10:17

This Drug Candidate Is Currently Used In A Pivotal Phase 3 Study For Patients With Advanced Liver Cancer And A Phase 2b Study F...

Can-fite Biopharma Says Its Veterinary Par...
06/28/2024 11:07:27

Can-Fite Announces New Findings on Namoden...
06/24/2024 11:04:22

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule dr...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
06/14/2024 20:31:12

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session

Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

Can-Fite Biopharma Says Its Phase 3 Study ...
06/05/2024 11:18:20

A compassionate use program has also been ongoing in Israel and Romania.

HC Wainwright & Co. Reiterates Buy on Can ...
05/09/2024 17:47:26

HC Wainwright & Co. analyst Vernon Bernardino reiterates Can Fite Biofarma (AMEX:CANF) with a Buy and maintains $18 pric...

The FDA Has Granted Investigational New Dr...
05/09/2024 12:21:58

Can-Fite Received Notice of Allowance from...
05/06/2024 11:04:23

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule dru...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
04/25/2024 12:06:47

Can-Fite Biopharma Announced It Published ...
04/25/2024 11:28:46

The Patient Participated In The Phase Ii Liver Cancer Study And Has Been Treated With Namodenoson For >7 Years Under Compass...

Can-Fite's Namodenoson Featured in Biomedi...
04/15/2024 11:06:38

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule dr...

Can-Fite BioPharma Submits FDA with an IND...
04/03/2024 11:03:06

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule dru...

Can Fite Biofarma: Q4 Earnings Insights
03/28/2024 11:50:05

Can Fite Biofarma FY GAAP EPS $(0.01), Sam...
03/28/2024 11:23:54

Can Fite Biofarma (AMEX:CANF) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year....

Can-Fite BioPharma Announced Notice Of All...
02/28/2024 12:12:11

Can-Fite Expands the Out-Licensing Deal wi...
01/30/2024 12:03:19

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule dru...

Can-Fite's Latest Innovation: Namodenoson ...
12/20/2023 12:07:16

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule dr...